 laboratori paramet safeti efficaci thrombolyt therapi thrombolyt therapi frequenc myocardi infarct MI pulmonari embol venou thrombosi dvt peripher arteri occlus use agent concern safeti efficaci numer laboratori paramet risk complic level fibrinogen percentag decreas fibrin/fibrinogen degrad product fdp variabl extent clinic bleed bleed time BT test potenti predictor thrombolyt therapi respect efficaci d-dimer fragment fdp solubl fibrin polym clot lysi venou thromboembol MI BT marker lysi patient dvt concomit use antiplatelet agent thrombolyt therapi BT vivo test hemostasi platelet function potenti util noninvas adjunct marker thrombolyt efficaci